Search

Glaucoma UK announces United Kingdom & Eire Glaucoma Society (UKEGS) Research Award 2024

Glaucoma UK is delighted to announce that this year’s UKEGS Research Award is now open to UKEGS members. The award, funded by Glaucoma UK and UKEGS, offers up to £50,000 for projects aimed at impacting patient care, scientific advancement, or understanding of glaucoma.

CHEC expands transformative MIGS service

CHEC, a community healthcare provider delivering specialist ophthalmology services on behalf of the NHS, has announced the expansion of its minimally invasive glaucoma surgery (MIGS) service. MIGS is an innovative approach combining glaucoma treatment with cataract surgery, utilising advanced techniques...

Report: Kabgayi International Ophthalmology Conference 2024

My journey to Rwanda in April 2022 aimed to expand vitreoretinal services, but it also highlighted the need for robust scientific discourse, akin to the UK's ophthalmology culture, and so we seized the opportunity to plan an 'international' ophthalmology conference to coincide with a visit from five of my former UK consultant colleagues.

Landmark review of glaucoma treatment and research published by Moorfields-led team

Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.

Introducing: iGLEAMS-3

30 September (Colchester FirstSite) – 1 October (Colchester ICENI Centre)

Report: UKEGS 2024

It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

The National Treatment Centre-Highland

The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.

Study shows laser treatment could significantly improve treatment for glaucoma in Africa

Results of a trial published in Lancet Global Health on 14/10/21 could pave the way for significant improvements in treatment for glaucoma in Sub-Saharan Africa.

Newmedica strengthens glaucoma services with optometrist-turned-ophthalmologist appointment

Newmedica, a leading provider of ophthalmology services across England, has appointed Richard Stead as its lead for glaucoma. This strategic move underscores Newmedica's commitment to delivering exceptional and timely care for both NHS and private patients across the spectrum of...

Welcome from Guest Editor Evelyn Mensah

I loved attending RCOphth Annual Congress face-to-face in Glasgow this year. How wonderful it was to see old friends and meet new after two pandemic years. At Congress I chaired the session on ‘Racism in the NHS’ with ‘three professors’...

RCOphth 2023 Preview

Here is our rundown of the RCOphth 2023 Annual Congress before it all kicks off, with dates for your diary, competitions, interviews and more!